live webinar · july 29 · 1PM ET
The Cannabis Inflection Point Is Here. Are You Ready?
Prohibition has kept most advisors on the sidelines for years - that is changing fast. With the DEA’s adult-use rescheduling review expected to conclude soon, the window to get ahead is now.
Join Dan Ahrens, Portfolio Manager behind the world's largest public cannabis fund franchise, for an exclusive briefing that will arm you to answer client questions with confidence.
In 45 minutes, Dan will break down:
• The Uplisting Wave: Why NYSE listings from major cannabis operators are a game-changing structural shift
• Post-Hearing Clarity: What the DEA's rescheduling hearing outcome means, and why compliance friction could loosen
• The Institutional Influx: How new capital and exchange access could reshape valuations and liquidity overnight.
Your clients will be asking soon. Make sure you have the answer first.
FOR FINANCIAL PROFESSIONALS ONLY.
Information you provide when registering will be shared with the account owner and host and can be used and shared by them in accordance with their Terms and Privacy Policy.
Before investing you should carefully consider the Fund’s investment objectives, risks, charges and expenses. This and other information is in the prospectus or summary prospectus, a copy of which may be obtained by visiting the Fund's website at www.AdvisorShares.com. Please read the prospectus and summary prospectus carefully before you invest. Foreside Fund Services, LLC, Distributor.
An investment in the Funds is subject to risk, including the possible loss of principal amount invested. The risks associated with each Fund include the risks associated with the underlying ETFs, which can result in higher volatility, and are detailed in each Fund’s prospectus and on each Fund’s webpage
Due to compliance regulations, this webinar is for financial professionals only.